Description
Receptor Tyrosine Kinases (EGFR/HER) Antibody Sampler Pack
The Receptor Tyrosine Kinases (EGFR/HER) Antibody Sampler Pack from Assay Genie brings together 8 rigorously validated antibodies spanning the key nodes of the Receptor Tyrosine Kinases (EGFR/HER) pathway. Each antibody is supplied in a convenient 20µL trial size, letting researchers screen an entire signalling axis in a single, cost-effective pack before committing to full-size vials — ideal for pathway mapping, target validation and multi-marker studies.
Receptor tyrosine kinases of the EGFR/HER family, together with MET, IGF-1R, FGFR and VEGFR, initiate downstream MAPK and PI3K signalling upon ligand-induced dimerisation and autophosphorylation. They are major oncogenic drivers and validated therapeutic targets across solid tumours.
All antibodies are individually quality-controlled and validated for applications including ELISA, IF/ICC, IHC-P, IP, WB, with reactivity across human, mouse and rat where indicated. Every target is also available in a full 100µL size for scale-up.
| Target | Antibody | Cat. No. | Host | Reactivity | Applications | Size |
| EGFR | Anti-EGFR Antibody -Knockout Validated | CAB11351-20 | Rabbit | Human, Mouse, Rat | WBIHC-PIF/ICCIPELISA | 20µL |
| Phospho-EGFR | Anti-Phospho-EGFR-Y1068 [ARC0013] Monoclonal Antibody | CABP0027-20 | Rabbit | Human, Mouse | WBELISA | 20µL |
| HER2/ErbB2 | Anti-HER2/ErbB2 Polyclonal Antibody | CAB21768-20 | Rabbit | Human | WBELISA | 20µL |
| HER3/ErbB3 | Anti-ErbB3/HER3 Antibody | CAB13976-20 | Rabbit | Human, Mouse, Rat | WBIF/ICCELISA | 20µL |
| c-Met | Anti-MET Antibody | CAB0040-20 | Rabbit | Human, Rat | WBELISA | 20µL |
| IGF-1R | Anti-INSR/IGF1R [ARC54074] Monoclonal Antibody | CAB21984-20 | Rabbit | Human, Mouse, Rat | WBELISA | 20µL |
| FGFR2 | Anti-FGFR2 [ARC0480] Monoclonal Antibody | CAB19051-20 | Rabbit | Human, Mouse, Rat | WBELISA | 20µL |
| VEGFR2 | Anti-VEGFR2/KDR/Flk-1/CD309 Polyclonal Antibody | CAB24671-20 | Rabbit | Mouse | WBELISA | 20µL |
Receptor tyrosine kinases of the EGFR/HER family, together with MET, IGF-1R, FGFR and VEGFR, initiate downstream MAPK and PI3K signalling upon ligand-induced dimerisation and autophosphorylation. They are major oncogenic drivers and validated therapeutic targets across solid tumours.
| Specification | Detail |
| Pack Format | 8 antibodies, 20µL each (trial size) |
| Storage | Store at -20°C upon receipt |
| Shelf Life | 12 months from date of receipt |
| Shipping | Gel pack |
| Scale-up | Every antibody is also available individually in a full 100µL size |
